Patents by Inventor Kalisankar Bera

Kalisankar Bera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250136553
    Abstract: The present disclosure describes acylsulfonamide compounds of Formula (J), and pharmaceutically acceptable salts, compositions, methods, and uses thereof. Such compounds are believed to be therapeutically useful as KAT6A inhibitors particularly in the treatment and/or prevention of diseases and disorders mediated by KAT6A in a subject.
    Type: Application
    Filed: December 23, 2024
    Publication date: May 1, 2025
    Inventors: Brian R. Hearn, David C. Myles, Reena Chawla, David Yeghikyan, Chandregowda Venkateshappa, Susanta Samajdar, Kalisankar Bera, Suraj Tatyasaheb Gore, Raymond A. Ng
  • Publication number: 20250059204
    Abstract: The present invention provides fused benzoisoxazolyl compounds represented by compound of formula (I), which are therapeutically useful as KAT6A inhibitors particularly in the treatment and/or prevention of the diseases or disorders mediated by KAT6A in a subject. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising at least one of the compounds of formula (I) or a pharmaceutically acceptable salt or a stereoisomer or a tautomer thereof.
    Type: Application
    Filed: December 12, 2022
    Publication date: February 20, 2025
    Inventors: Chandregowda Venkateshappa, Kalisankar Bera, Chandrasekhar Abbineni, Susanta Samajdar, David C. Myles, Brian R. Hearn
  • Publication number: 20240254139
    Abstract: The present invention provides fused isoxazolyl compound of formula (I), which are therapeutically useful as KAT6A inhibitors particularly in the treatment and/or prevention of diseases or disorders dependent upon KAT6A in a mammal. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising at least one of the compound represented by formula (I) or a pharmaceutically acceptable salt or a stereoisomer or a tautomer thereof.
    Type: Application
    Filed: May 21, 2022
    Publication date: August 1, 2024
    Inventors: Chandregowda Venkateshappa, Chandrasekhar Abbineni, Susanta Samajdar, Kalisankar Bera